Effects of amyloid beta and dopaminergic depletion on perfusion and clinical symptoms
Alzheimer's & Dementia · 2023-12 · 19 (12) · 5719-5729
DOI: 10.1002/alz.13379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 08.07.2023. Verfasst von Young-Gun Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Lewy Body Disease. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Technology R&D, Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea, National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
INTRODUCTION Although mixed pathologies are common in Alzheimer's disease (AD) and dementia with Lewy bodies (DLB), the effects of amyloid beta and dopaminergic depletion on brain perfusion and clinical symptoms have not been elucidated. METHODS In 99 cognitive impairment patients due to AD and/or DLB and 32 controls, 18F‐florbetaben (FBB) and dual‐phase dopamine transporter (DAT) positron emission tomography (PET) were performed to measure the FBB standardized uptake value ratio (SUVR), striatal DAT uptakes, and brain perfusion. RESULTS Higher FBB‐SUVR and lower ventral striatal DAT uptake were intercorrelated and, respectively, associated with left entorhinal/temporo‐parietal‐centered hypoperfusion and vermis/hippocampal‐centered hyperperfusion, whereas regional perfusion mediated clinical symptoms and cognition. DISCUSSION Amyloid beta deposition and striatal dopaminergic depletion contribute to regional perfusion changes, clinical symptoms, and cognition in the spectrum of normal aging and cognitive impairment due to AD and/or LBD. Highlights Amyloid beta (Aβ) deposition was associated with ventral striatal dopaminergic depletion. Aβ deposition and dopaminergic depletion correlated with perfusion. Aβ deposition correlated with hypoperfusion centered in the left entorhinal cortex. Dopaminergic depletion correlated with hyperperfusion centered in the vermis. Perfusion mediated the Aβ deposition/dopaminergic depletion's effects on cognition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
- Department of Neurology, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South Korea.
- Brain Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
- Metabolism-Dementia Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Förderung
- Korea Health Technology R&D
- Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea
- National Research Foundation of Korea (NRF)
- Korean government (MSIT)
Zitieren
APA
Lee, Y. G., Jeon, S., Kang, S. W., & Ye, B. S. (2023). Effects of amyloid beta and dopaminergic depletion on perfusion and clinical symptoms. Alzheimer's & Dementia, 19(12), 5719-5729. https://doi.org/10.1002/alz.13379
Vancouver
Lee YG, Jeon S, Kang SW, Ye BS. Effects of amyloid beta and dopaminergic depletion on perfusion and clinical symptoms. Alzheimer's & Dementia. 2023;19(12):5719-5729. doi:10.1002/alz.13379
BibTeX
@article{Lee2023,
author = {Lee, Young-Gun and Jeon, Seun and Kang, Sung Woo and Ye, Byoung Seok},
title = {Effects of amyloid beta and dopaminergic depletion on perfusion and clinical symptoms},
journal = {Alzheimer's & Dementia},
year = {2023},
volume = {19},
number = {12},
pages = {5719--5729},
doi = {10.1002/alz.13379}
}
EUVIMED